Literature DB >> 11890237

Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?

H W Herr1.   

Abstract

OBJECTIVE: To correlate the cystoscopic appearance of recurrent papillary bladder tumours with the histology after transurethral resection, and thus ascertain whether cystoscopy can reliably identify low-grade, noninvasive papillary tumours suitable for outpatient fulguration. PATIENTS AND METHODS: In all, 150 recurrent papillary tumours of the bladder identified at outpatient flexible cystoscopy were classified as either low-grade and noninvasive (TaG1), high-grade and noninvasive (TaG3), or invasive (TIG3) tumours, and correlated with urine cytology and histology of tumour stage and tumour grade after transurethral resection.
RESULTS: Cystoscopy classified 84 of the 150 papillary tumours as TaG1 and 66 as either TaG3 or T1G3. Cystoscopy correctly predicted the histology of 78 of 84 (93%) TaG1 tumours, 71 of 72 (98%) TaG1 tumours associated with a negative urine cytology, and 92% of TaG3 or T1G3 tumours.
CONCLUSIONS: A skilled urologist can identify noninvasive, low-grade recurrent papillary bladder tumours on follow-up cystoscopy that do not require biopsy and that may be treated by outpatient fulguration alone.

Entities:  

Mesh:

Year:  2001        PMID: 11890237     DOI: 10.1046/j.1464-4096.2001.02396.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

Review 1.  [Photodynamic diagnostics of bladder carcinoma].

Authors:  F Vom Dorp; S Tschirdewahn; T Olbricht; T Szarvas; H Rübben
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Residual stones after percutaneous nephrolithotomy: comparison of intraoperative assessment and postoperative non-contrast computerized tomography.

Authors:  Ahmed M Harraz; Yasser Osman; Ahmed R El-Nahas; Amr A Elsawy; Islam Fakhreldin; Osama Mahmoud; Ahmed El-Assmy; Ahmed A Shokeir
Journal:  World J Urol       Date:  2016-12-24       Impact factor: 4.226

Review 3.  Expectant Management of Low-Risk Bladder Cancer.

Authors:  Zachary L Smith; Mark S Soloway
Journal:  Curr Urol Rep       Date:  2015-12       Impact factor: 3.092

Review 4.  [Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder].

Authors:  S Tschirdewahn; F Vom Dorp
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

5.  [Exfoliative urine cytology in the treatment of bladder cancer].

Authors:  S Tschirdewahn; F Vom Dorp; H Rübben; O W Hakenberg
Journal:  Urologe A       Date:  2011-03       Impact factor: 0.639

6.  Bladder cancer: Lack of progress in bladder cancer--what are the obstacles?

Authors:  Mark S Soloway
Journal:  Nat Rev Urol       Date:  2012-11-20       Impact factor: 14.432

7.  Audit of safety, efficacy, and cost-effectiveness of local anaesthetic cystodiathermy.

Authors:  Kim Davenport; Francis X Keeley; Anthony G Timoney
Journal:  Ann R Coll Surg Engl       Date:  2010-07-02       Impact factor: 1.891

Review 8.  [Intravesical therapy of non-muscle invasive bladder tumors].

Authors:  F Vom Dorp; S Tschirdewahn; G Lümmen
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

Review 9.  Approaching the optimal transurethral resection of a bladder tumor.

Authors:  Michael Jurewicz; Mark S Soloway
Journal:  Turk J Urol       Date:  2014-06

Review 10.  Active surveillance for nonmuscle invasive bladder cancer.

Authors:  Makito Miyake; Kiyohide Fujimoto; Yoshihiko Hirao
Journal:  Investig Clin Urol       Date:  2016-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.